Scientist analyzing genomic data in a molecular diagnostics lab

Advancing Care Through
Precision Molecular
diagnostics

Comprehensive genomic testing across cancer, rare diseases, infections, transplantations, pharmacogenomics, and reproductive health.

Advanced Clinical Molecular Diagnostics

From genomic profiling to real-time monitoring, our comprehensive platform transforms molecular data into clinical decisions.

Tumor Genomic Profiling

Tumor Genomic Profiling

Learn More

Tumor Genomic Profiling

Comprehensive sequencing of tumor DNA and RNA to identify actionable mutations, copy number variations, and gene fusions across hundreds of cancer-related genes.

Learn More
Liquid Biopsy

Liquid Biopsy

Learn More

Liquid Biopsy

Non-invasive tracking of circulating tumor DNA (ctDNA) from a simple blood draw to monitor treatment response and detect minimal residual disease (MRD) earlier.

Learn More
Hereditary Cancer Risk

Hereditary Cancer Risk

Learn More

Hereditary Cancer Risk

Germline testing of key susceptibility genes (like BRCA1/2, Lynch Syndrome genes) to evaluate inherited cancer risk and guide preventative strategies.

Learn More
Pharmacogenomics

Pharmacogenomics

Learn More

Pharmacogenomics

Analysis of genetic variations affecting drug metabolism, enabling precision dosing and minimizing adverse effects for oncology therapeutics.

Learn More
Neuro-Oncology Panels

Neuro-Oncology Panels

Learn More

Neuro-Oncology Panels

Targeted sequencing for central nervous system tumors, identifying diagnostic markers (like IDH1/2, 1p/19q codeletion) crucial for WHO classification.

Learn More
Hematologic Malignancies

Hematologic Malignancies

Learn More

Hematologic Malignancies

Deep molecular characterization of leukemias, lymphomas, and myelomas to refine prognosis and identify specific targets for advanced immunotherapies.

Learn More
Viral Pathogenesis

Viral Pathogenesis

Learn More

Viral Pathogenesis

Detection and quantification of oncogenic viruses (like HPV, EBV) integrated into the host genome, critical for staging and therapeutic selection.

Learn More
Immune Profiling

Immune Profiling

Learn More

Immune Profiling

Evaluation of tumor mutational burden (TMB) and microsatellite instability (MSI) to predict patient response to immune checkpoint inhibitors.

Learn More
Lung Cancer Panels

Lung Cancer Panels

Learn More

Lung Cancer Panels

Rapid evaluation of key biomarkers (EGFR, ALK, ROS1, RET) to immediately inform first-line targeted therapies for non-small cell lung cancer.

Learn More
Minimal Residual Disease

Minimal Residual Disease

Learn More

Minimal Residual Disease

Ultra-sensitive, patient-specific assays designed to detect microscopic levels of cancer post-surgery or post-treatment, anticipating relapse before imaging.

Learn More
Scientist pipetting a genomic sample in the laboratory

More Than a Laboratory-
Defining Precision Through
Genomics.

3D Genomix Healthcare is a data-driven molecular diagnostics and precision oncology organization focused on advancing cancer care through deep molecular insights.

Built On Three Pillars

From genomic profiling to real-time monitoring, our comprehensive platform transforms molecular data into clinical decisions.

Data- The Foundation

Data- The Foundation

High-quality molecular data forms the foundation for precision diagnostics, enabling earlier detection, personalized treatment planning, and more confident clinical decisions.

Data-Driven Intelligence- The Engine

Data-Driven Intelligence- The Engine

Advanced bioinformatics and machine-learning-based approaches enable rigorous, interpretable analysis of genomic and multi-omic data.

Diagnosis- The outcome

Diagnosis- The outcome

Accurate, timely diagnosis informs therapeutic decisions, supports ongoing monitoring, and enables treatment adaptation for improved outcomes and clinical confidence.

Solving the Core Challenges in Modern Cancer Care

  • Two patients, same diagnosis, different molecular drivers.
  • Resistance can emerge without warning.
  • Testing is fragmented across labs.
  • Sensitive strategies for early detection or real-time treatment monitoring remain limited.
Microscopic rendering of a cancer cell
Doctor comforting a patient during a consultation

Our Approach towards the challenges

  • Comprehensive genomic profiling.
  • Unified bioinformatics platform.
  • Therapy decisions informed by molecular drivers.
  • Actionable insights for clinical decision-making.
  • Longitudinal monitoring with liquid biopsy.
  • Early resistance detection via MRD.

About Genomix

Guiding precision healthcare through data-driven molecular diagnostics and clinical partnership.

Contact Us